BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4471340)

  • 1. [Seroimmunological studies in vesicular mole].
    Montemagno U; Cardone A; Tolino A
    Arch Ostet Ginecol; 1974; 79(3-4):171-87. PubMed ID: 4471340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Criteria for the clinical management of vesicular mole. A polycentric study of 383 cases].
    Bolis G; Pecorelli S; Belloni C; Sartori E; Valente I; Ratti E; Fasoli M
    Minerva Ginecol; 1982 Jun; 34(6):419-24. PubMed ID: 7133526
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies of choriocarcinoma. IV. The antigenicity of trophoblast.
    Májský A; Jakoubková J; Zavadil M
    Neoplasma; 1969; 16(1):63-9. PubMed ID: 4306759
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of vesicular mole].
    Attual Ostet Ginecol; 1967; 12(3):171-8. PubMed ID: 5627488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endometrial histological aspects after antiblastic treatment for vesicular mole].
    Albano V; Ragonese P
    Riv Anat Patol Oncol; 1969; 35():88-94. PubMed ID: 5408635
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of human leukocyte antigen G expression in hydatidiform moles.
    Goldman-Wohl D; Ariel I; Greenfield C; Hochner-Celnikier D; Lavy Y; Yagel S
    Am J Obstet Gynecol; 2001 Aug; 185(2):476-80. PubMed ID: 11518912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A re-evaluation of trophoblastic diseases: syncytial endometritis, hydatidiform mole (benign and malignant) and choriocarcinoma.
    Villasanta U
    Indian Pract; 1966 May; 19(5):329-34. PubMed ID: 5938362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hydatidiform mole: advances-diagnosis-therapy].
    Grunstein S; Jaschevatzky OE; Shalit A
    Prensa Med Argent; 1970 Jul; 57(21):1006-10. PubMed ID: 5478158
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy in the treatment of undelivered hydatidiform mole. A study of 5 cases.
    Ma HK; Yip SK; Chun D
    J Obstet Gynaecol Br Commonw; 1971 Jan; 78(1):80-6. PubMed ID: 5104985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chorioepithelioma with methotrexate].
    Mladenović D; Srbinović L; Prica R; Vućić V; Marković A
    Srp Arh Celok Lek; 1972 Jan; 100(1):76-84. PubMed ID: 5063781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of chorial malignancy].
    Chapero L
    Rev Chil Obstet Ginecol; 1972; 37(2):50-8. PubMed ID: 4669136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of antineoplastic agents on the ovarian function in the patient after excision of hydatidiform mole].
    Nagai S; Abiko S; Nakaya K; Numata F; Hayashi N
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Feb; 19(2):179-82. PubMed ID: 5624225
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of villous tumors--with special reference to the effect of methotrexate therapy].
    Torigoe T; Moriwaki K; Yamasato Y; Kunishige T
    Sanfujinka No Jissai; 1967 Mar; 16(3):267-71. PubMed ID: 5899925
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of levamisole as an immunomodulating agent in trophoblastic lesions.
    Khanna A; Ojha KN; Gupta RM
    Indian J Pathol Microbiol; 1993 Jan; 36(1):32-7. PubMed ID: 8354552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular irritation from low-dose methotrexate.
    Hussain MI
    Cancer; 1982 Aug; 50(3):605. PubMed ID: 7201342
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of inhibin/activin subunits, sialyl-lewis A (CA 19-9, sLea) and sialyl-Lewis X (sLex) carbohydrate antigens in a hydatidiform mole with persistent polymorphic trophoblastic hyperplasia.
    Mylonas I; Makovitzky J; Vogel M; Shabani N; Jeschke U; Friese K
    Anticancer Res; 2005; 25(3A):1725-30. PubMed ID: 16033091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excretion of estrogens and pregnanediol in women with hydatid mole treated with methotrexate].
    Skriuchenkova VA; Ozerianskaia AL; Vinogradova EI
    Akush Ginekol (Mosk); 1973 Nov; 49(11):68-9. PubMed ID: 4799495
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemoprophylaxis and chemotherapy of hydatidiform mole].
    Marsiletti GC
    Attual Ostet Ginecol; 1968; 1():52-75. PubMed ID: 5754750
    [No Abstract]   [Full Text] [Related]  

  • 20. Further immunologic studies in patients with choriocarcinoma and hydatidiform mole.
    Robinson E; Ben-Hur N; Zuckerman H; Neuman Z
    Cancer Res; 1967 Jul; 27(7):1202-4. PubMed ID: 4952512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.